|
News Release
Imaging3 and Oregon Health & Science University to Partner as First Luminary Site for the Dominion
BURBANK, Calif. & PORTLAND, Ore.--(BUSINESS WIRE)--Imaging3(TM), Inc., (OTCBB:IMGG - News), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, today announced that the company has closed a deal to make Oregon Health & Science University in Portland, Oregon the first of numerous planned luminary sites for the company's ground-breaking Dominion(TM) device.
OHSU is a public university that houses two of the state's largest hospitals, Oregon Health & Science University Hospital and Doernbecher Children's Hospital, in addition to a number of outpatient and research facilities. OHSU has been acknowledged for a number of clinical and research breakthroughs in the areas of cancer, children's health, computer technology, genetics, trauma care, heart disease, hearing, infectious disease, general medicine, reproduction, mental health, interventional radiology, neurosciences, and nursing - among others.
Nationally and internationally recognized, OHSU is among the most respected hospitals in the West. US News & World Report has ranked Oregon Health & Science University in the "America's Best Hospital Ratings" for twelve years, most recently in 2006. In addition, for the seventh consecutive year, OHSU received the Consumer Choice Award for the Portland-metro area by the National Research Corporation
In December of last year, Imaging3 was approached by internationally acclaimed radiation oncologist Dr. Martin Fuss, Professor and Director of the Image-Guided Radiation Therapy Program of OHSU's Department of Radiation Medicine. "We are excited about the potential of the Dominion mobile cone-beam CT and real-time fluoroscopy device and its use in Radiation Oncology, particularly in the rapidly developing area of image-guided radiation therapy (IGRT). We truly feel that this collaboration will allow us to make significant improvements in how we currently deliver radiation therapy to cancer patients."
"Imaging3 is extremely pleased to be working with such an esteemed university hospital to further develop our product in this ever evolving niche," stated Dean Janes, Chairman and CEO, Imaging3.
For more information on Oregon Health & Science University and the Department of Radiation Medicine, visit www.ohsu.edu/radonc. To learn more about Imaging3's Dominion, visit www.imaging3.com.
About Imaging3, Inc.
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough technology (patented) that will produce 3D medical diagnostic images in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body.
Imaging3 Technology can to contribute to the improvement of healthcare. By providing this higher quality and quantity of information, the physician or clinician will be able to perform any procedure with a higher level of accuracy while decreasing the time spent performing the procedure. By increasing throughput while increasing diagnostic and clinical accuracy, Imaging3 Technology becomes an attractive new technology that will provide healthcare centers with a high return on investment.
For more information about Imaging3, Inc., please visit the Company's Web site
www.Imaging3.com
About OHSU
Oregon Health & Science University is the state of Oregon's only health and research university. OHSU's fundamental purpose is to improve the well-being of people in Oregon and beyond. As part of its multifaceted public mission, OHSU strives for excellence in scholarship, research, clinical practice and community service.
OHSU has two hospitals and numerous primary care and specialty practices treating over 175,000 patients yearly making us one of the largest providers of care in the Pacific Northwest.
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.
Contact:
Imaging3, Inc.
Media Relations
(818) 260-0930
|
|
